Charo's husband Kjell Rasten was suffering from bullous pemphigoid prior to his death Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to tennis to Simone Biles ...
The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...
Bullous pemphigoid is a potentially debilitating autoimmune bullous disease presenting with urticarial plaques, subepidermal bullae, erosions, and pruritus, classically in elderly individuals. This ...
Proteomic profiling reveals molecular clusters and severity biomarkers in bullous pemphigoid, highlighting disease ...
Please provide your email address to receive an email when new articles are posted on . Dupixent previously received priority review and orphan drug designation from the FDA for bullous pemphigoid.
This page lists all known medications that could potentially lead to 'Pemphigoid' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...
Please provide your email address to receive an email when new articles are posted on . Sustained disease remission occurred in 20% of the study cohort vs. 4% of the placebo group at week 36. 41% of ...
Pemphigoid gestationis (PG) is a rare, itchy skin eruption that usually happens in the second or third trimester of pregnancy. It often begins with the appearance of very itchy red bumps or blisters ...
A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
Pemphigoid gestationis is a rare autoimmune skin condition that may develop during pregnancy. It can cause an itchy rash and blisters. However, treatments such as corticosteroids can help. Pemphigoid ...
Pemphigoid is a family of rare autoimmune conditions that causes blistering and rashes on the skin and mucous membranes. The body mistakenly sends antibodies to bind to cells in the skin. These ...